SCHEDULE 13G: Greenfield Investments and Peter M. Karam Disclose Significant Stake in Mangoceuticals, Inc.

Greenfield Investments, Ltd and Peter M. Karam have jointly disclosed a beneficial ownership of 14.44% in Mangoceuticals, Inc.'s common stock, totaling 515,000 shares.

Summary

• Greenfield Investments, Ltd and Peter M. Karam have filed a Schedule 13G, reporting their beneficial ownership in Mangoceuticals, Inc.
• As of January 22, 2025, the reporting persons collectively beneficially own 515,000 shares of Mangoceuticals, Inc. Common Stock.
• This ownership represents 14.44% of the company's outstanding common stock.
• The percentage is calculated based on 3,565,641 shares of Mangoceuticals, Inc. outstanding as of January 22, 2025, as confirmed by the Issuer's transfer agent.
• Both Greenfield Investments, Ltd and Peter M. Karam share voting and dispositive power over all 515,000 shares.
• The securities were not acquired and are not held for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While a Schedule 13G is a factual disclosure, the emergence of a significant new beneficial owner (14.44%) can be viewed positively by the market as it indicates investor confidence and a substantial stake being taken, without an intent to influence control, suggesting a belief in the company's current direction.

Positives

• The disclosure of a significant 14.44% stake by Greenfield Investments, Ltd and Peter M. Karam may signal confidence from these investors in Mangoceuticals, Inc.'s future prospects.
• The filing explicitly states that the shares were not acquired for the purpose of changing or influencing control, suggesting a passive investment intent.

Future Outlook

NA

Industry Context

This filing indicates a significant passive investment in Mangoceuticals, Inc. by a specific entity and individual. Such disclosures are common in the market and provide transparency regarding major shareholdings, which can influence investor perception of a company's stability and attractiveness.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by Greenfield Investments, Ltd and Peter M. Karam could be perceived positively, potentially increasing investor confidence and market stability due to a large, seemingly passive, long-term holder.

Key Dates

Keywords

Mangoceuticals Inc., Greenfield Investments Ltd, Peter M. Karam, Schedule 13G, Beneficial Ownership, Common Stock, Equity Stake, SEC Filing, Investment Disclosure, Shareholding